RT Journal Article SR Electronic T1 Pfizer's DRUMBEAT Program JF PDA Journal of Pharmaceutical Science and Technology JO PDA J Pharm Sci Technol FD Parenteral Drug Association (PDA) SP 217 OP 233 VO 34 IS 3 A1 Kenneth G. Chapman YR 1980 UL http://journal.pda.org/content/34/3/217.abstract AB Proposed large-volume parenterals (LVP’s) represent only one of many sets of complex new GMP regulations introduced in the 1970’s. Many require a variety of written procedures. Pfizer Inc., multinational producer of ethical and OTC pharmaceuticals (including component bulk chemicals), medical devices (critical and non-critical), cosmetics, food additive chemicals, medicated animal feed premixes, and other products, found most of its product line affected. Quality assurance’s DRUMBEAT system reduces all GMP’s into a simple package, permitting Pfizer to quickly match its thousands of written procedures, for example, against regulatory requirements. Versatility of the system makes it applicable to a wide variety of similar problems.